𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A case of ototoxicity in a patient with metastatic carcinoma of the breast treated with paclitaxel and vinorelbine

✍ Scribed by C. Tibaldi; I. Pazzagli; S. Berrettini; A. De Vito

Book ID
117664201
Publisher
Elsevier Science
Year
1998
Tongue
English
Weight
31 KB
Volume
34
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Central nervous system progression of me
Central nervous system progression of metastatic breast cancer in patients treated with paclitaxel
✍ Ronnie J. Freilich; Andrew D. Seidman; Dr. Lisa M. Deangelis πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 474 KB πŸ‘ 2 views

Background. The possibility of tumor sanctuary sites in the central nervous system (CNS) of patients receiving paclitaxel has been suggested by laboratory data identifying low concentrations of drug in the brain and cerebrospinal fluid (CSF) of rats. Methods. The pattern of disease progression in p

Outcome of patients with metastatic brea
Outcome of patients with metastatic breast carcinoma treated at a private medical oncology clinic
✍ William F. Anderson; James E. Reeves; Abdalla Elias; Hans (J) Berkel πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 136 KB πŸ‘ 2 views

## BACKGROUND. Metastatic breast carcinoma usually is fatal. The median survival after recurrence is 2 years. Five-year survival after recurrence is approximately 10 -20%. Although encouraging data have been reported from clinical trials, two issues confound the translation of clinical research to